Drug Type Small molecule drug |
Synonyms SCH 351633, SCH-351633 |
Target |
Action inhibitors |
Mechanism NS3 inhibitors(Hepatitis C virus (HCV) nonstructural protein 3 inhibitors), NS3/NS4A inhibitors(Hepatitis C virus serine protease, NS3/NS4A inhibitors) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhasePendingPreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Hepatitis C | Preclinical | United States | 19 Jul 1999 |